Evidence map›Paper›PMID 31929853›Full record

ArticleOxidative medicine and cellular longevity2019

Prognostic Value of Oxidative Stress Markers in Patients with Pulmonary Arterial or Chronic Thromboembolic Pulmonary Hypertension.

Anna Smukowska-Gorynia, Piotr Rzymski, Justyna Marcinkowska, Barbara Poniedziałek, Anna Komosa, Artur Cieslewicz, Sylwia Slawek-Szmyt, Magdalena Janus, Aleksander Araszkiewicz, Stanislaw Jankiewicz and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Risk Factors of Pulmonary Hypertension in Patients on Hemodialysis: A Single Center Study.International journal of nephrology and renovascular disease · 2021
    Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Anna Smukowska-Gorynia1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.ORCID https://orcid.org/0000-0002-0738-7952
Piotr RzymskiDepartment of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland.ORCID https://orcid.org/0000-0002-4713-0801
Justyna MarcinkowskaDepartment of Computer Science and Statistics, Poznan University of Medical Sciences, Poznan, Poland.
Barbara PoniedziałekDepartment of Environmental Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Anna Komosa1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Artur CieslewiczDepartment of Clinical Pharmacology, Poznan University of Medical Sciences, Poznan, Poland.
Sylwia Slawek-Szmyt1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Magdalena Janus1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Aleksander Araszkiewicz1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Stanislaw Jankiewicz1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Iga Tomaszewska-Krajniak1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Tatiana Mularek-Kubzdela1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland.
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress is regarded to play a crucial role in the pathophysiology of pulmonary arterial hypertension (PAH) and inoperable chronic thromboembolic pulmonary hypertension (CTEPH). This study evaluated the prognostic value of serum oxidative stress markers (malondialdehyde (MDA), total antioxidant capacity (TAC), catalase activity (CAT), and superoxide activity (SOD)) in patients with PAH and CTEPH (

Indexed as

AdultAgedBiomarkersCatalaseChronic DiseaseDisease ProgressionFemaleFollow-Up StudiesHumansHypertension, PulmonaryMaleMalondialdehydeMiddle AgedOxidative StressPrognosisPulmonary EmbolismBiomarkersCatalaseMalondialdehydeSuperoxides

Identifiers

PMID31929853
PMCPMC6939433
OpenAlexW2995428684

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.